| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Tech Operations Officer
1 company
Christopher Horan is Chief Tech Operations Officer at ARTV. Christopher Horan's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $1.3M at current prices.
The ARTV filings lean toward selling, a net 38,131 shares.
Christopher Horan has 11 Form 4 filings on record from September 2024 to November 2026, all as Chief Tech Operations Officer at Artiva Biotherapeutics (ARTV), 2024–2026.
The 17 reported transactions were 5 stock awards, 4 open-market sales, 4 tax withholdings and 3 dispositions back to the company, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 4 sales worth about $293K.
The largest open-market sale was 10,366 shares of ARTV at an average $11.16 on September 3, 2026, about $116K.
None of the 4 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 2, 2026 | ARTV Artiva Biotherapeutics, Inc. | Chief Tech Operations Officer | Sell | 10,423 | $4.18 | $43,579.61 | -3.3% | - | - | |
| Oct 5, 2026 | ARTV Artiva Biotherapeutics, Inc. | Chief Tech Operations Officer | Sell | 10,340 | $6.84 | $70,696.65 | -3.2% | - | - | |
| Sep 3, 2026 | ARTV Artiva Biotherapeutics, Inc. | Chief Tech Operations Officer | Sell | 10,366 | $11.16 | $115,637.91 | -3.5% | - | - | |
| May 19, 2026 | ARTV Artiva Biotherapeutics, Inc. | Chief Tech Operations Officer | Sell | 7,002 | $9.01 | $63,072.62 | -2.3% | +37.3% | - |